Sign in

Trial site

Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E.

Lisbon, 1099-023, PortugalNot linked to an institution yet
  • 57running trials
  • 11closed trials

The trials here

What the 68 trials at this site are about, from their registry records.

Phase
  • Phase 346 trials
  • Phase 28 trials
  • Phase 1/25 trials
  • Phase 2/35 trials
  • Phase 42 trials
Status
  • Recruiting31 trials
  • Active, not recruiting24 trials
  • Completed10 trials
  • Not yet recruiting2 trials
  • Terminated1 trial
Lead sponsor
  • Merck Sharp & Dohme LLC7 trials
  • AstraZeneca3 trials
  • Mirati Therapeutics Inc.3 trials
  • Amgen2 trials
  • Bristol-Myers Squibb2 trials
  • and 46 more

Running trials

Showing 50 of 57.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Site data: ClinicalTrials.govUpdated 18 Nov 2026

Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E.: trial site – Frontlight Research